SEARCH

SEARCH BY CITATION

References

  • Albiero E, Ruggeri M, Fortuna S, Bernardi M, Finotto S, Madeo D, Rodeghiero F. 2011. Analysis of the oxygen sensing pathway genes in familial chronic myeloproliferative neoplasms and identification of a novel EGLN1 germline mutation. Br J Haematol 153:405408.
  • Albiero E, Ruggeri M, Fortuna S, Finotto S, Bernardi M, Madeo D, Rodeghiero F. 2012. Isolated erythrocytosis: study of 67 patients and identification of three novel germ-line mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene. Haematologica 7:123127.
  • Ang SO, Chen H, Gordeuk VR, Sergueeva AI, Polyakova LA, Miasnikova GY, Kralovics R, Stockton DW, Prchal JT. 2002a. Endemic polycythemia in Russia: mutation in the VHL gene. Blood Cells Mol Dis 28:5762.
  • Ang SO, Chen H, Hirota K, Gordeuk VR, Jelinek J, Guan Y, Liu E, Sergueeva AI, Miasnikova GY, Mole D, Maxwell PH, Stockton DW, et al. 2002b. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 32:614621.
  • Al-Sheikh M, Mazurier E, Gardie B, Casadevall N, Galactéros F, Goossens M, Wajcman H, Préhu C, Ugo V. 2008. A study of 36 unrelated cases with pure erythrocytosis revealed three new mutations in the erythropoietin receptor gene. Haematologica 93:10721075.
  • Arcasoy MO, Degar BA, Harris KW, Forget BG. 1997. Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene. Blood 89:46284635.
  • Arcasoy, MO. 2002. A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis. Blood 99:30663069.
  • Astuti D, Ricketts CJ, Chowdhury R, McDonough MA, Gentle D, Kirby G, Schlisio S, Kenchappa RS, Carter BD, Kaelin WG Jr, Ratcliffe PJ, Schofield CJ, et al. 2011. Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility. Endocr Relat Cancer 18:7383.
  • Benesch RE, Benesch R, Yu CI. 1969. The oxygenation of hemoglobin in the presence of 2,3-diphosphoglycerate. Effect of temperature, pH, ionic strength, and hemoglobin concentration. Biochemistry 8:25672571.
  • Bento MC, Ribeiro ML, Cunha E, Rebelo U, Granjo E, Granado C, Tamagnini, GP. 2000. Hb Vila Real [beta36(C2)Pro–>His]: a newly discovered high oxygen affinity variant. Hemoglobin 24:5963.
  • Bento MC, Chang KT, Guan Y, Liu E, Caldas G, Gatti RA, Prchal JT. 2005. Congenital polycythemia with homozygous and heterozygous mutations of von Hippel–Lindau gene: five new Caucasian patients. Haematologica 90:128129.
  • Bento MC, Cario H, Vidan J, Villegas A, Ribeiro ML. 2006. Congenital erythrocytosis and polycythemia vera in children and adolescents—an online database for registration of patients and data collection. Haematologica 91:3839.
  • Bento C, Almeida H, Fernandez-Lago C, Ribeiro ML. 2013a. Primary familial congenital erythrocytosis: two novel EPOR mutations found in Spain. Int J Lab Hematol. 35:e2728.
  • Bento C, Almeida H, Maia TM, Relvas L, Oliveira AC, Rossi C, Girodon F, Fernandez-Lago C, Aguado-Diaz A, Fraga C, Costa RM, Araújo AL, Silva J, Vitória H, Miguel N, Silveira MP, Martin-Nuñez G, Ribeiro ML. 2013b. Molecular study of congenital erythrocytosis in 70 unrelated patients revealed a potential causal mutation in less than half of the cases (Where is/are the missing gene(s)?). Eur J Haematol. 91:361368.
  • Bond J, Gale DP, Connor T, Adams S, de Boer J, Gascoyne DM, Williams O, Maxwell PH, Ancliff PJ. 2011. Dysregulation of the HIF pathway due to VHL mutation causing severe erythrocytosis and pulmonary arterial hypertension. Blood 117:36993701.
  • Bushuev VI, Miasnikova GY, Sergueeva AI, Polyakova LA, Okhotin D, Gaskin PR, Debebe Z, Nekhai S, Castro OL, Prchal JT, Gordeuk VR. 2006. Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia. Haematologica 91:744749.
  • Capodimonti S, Teofili L, Martini M, Cenci T, Iachininoto MG, Nuzzolo ER, Bianchi M, Murdolo M, Leone G, Larocca LM. 2012. Von Hippel–Lindau disease and erythrocytosis. J Clin Oncol 30:e137e139.
  • Cario H, Schwarz K, Jorch N, Kyank U, Petrides PE, Schneider DT, Uhle R, Debatin KM, Kohne E. 2005. Mutations in the von Hippel–Lindau (VHL) tumor suppressor gene and VHL-haplotype analysis in patients with presumable congenital erythrocytosis. Haematologica 90:1924.
  • Cario H, McMullin MF, Bento C, Pospisilova D, Percy MJ, Hussein K, Schwarz J, Åström M, Hermouet S. 2013. Erythrocytosis in children and adolescents—classification, characterization and consensus recommendations for the diagnostic approach. Pediatr Blood Cancer. 60:17341738.
  • Charache S, Weatherall DJ, Clegg JB. 1966. Polycythemia Associated with a hemoglobinopathy. J Clin Invest 45:813822.
  • Sable CA, Aliyu ZY, Dham N, Nouraie M, Sachdev V, Sidenko S, Miasnikova GY, Polyakova LA, Sergueeva AI, Okhotin DJ, Bushuev V, Remaley AT, et al. 2012. Pulmonary artery pressure and iron deficiency in patients with upregulation of hypoxia sensing due to homozygous VHLp.Arg200Trp mutation (Chuvash polycythemia). Haematologica 97:193200.
  • Cross NCP. 2011. Genetic and epigenetic complexity in myeloproliferative neoplasms. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 208214.
  • den Dunnen JT, Antonarakis SE. 2003. Mutation nomenclature. Curr Protoc Hum Genet. Chapter 7:Unit 7.13
  • Fairbanks VF, Maldonado JE, Charache S, Boyer SH. 1971. Familial erythrocytosis due to electrophoretically undetectable hemoglobin with impaired oxygen dissociation (hemoglobin Malmo, alpha 2 beta 2 97 gln). Mayo Clin Proc 46:721727.
  • Favier J, Buffet A, Gimenez-Roqueplo AP. 2012. HIF2A mutations in paraganglioma with polycythemia. N Engl J Med 367:21612162.
  • Finazzi G, Gregg XT, Barbui T, Prchal JT. 2006. Idiopathic erythrocytosis and other non-clonal polycythemias. Best Pract Res Clin Haematol 19:47182.
  • Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT. 2011. LOVD v.2.0: the next generation in gene variant databases. Hum Mutat 32:557563.
  • Formenti F, Constantin-Teodosiu D, Emmanuel Y, Cheeseman J, Dorrington KL, Edwards LM, Humphreys SM, Lappin TR, McMullin MF, McNamara CJ, Mills W, Murphy JA, et al. 2010. Regulation of human metabolism by hypoxia-inducible factor. Proc Natl Acad Sci USA 107:1272212727
  • Formenti F, Beer PA, Croft QP, Dorrington KL, Gale DP, Lappin TRJ, Lucas GS, Maher ER, Maxwell PH, McMullin MF, O'Connor DF, Percy MJ, et al. 2011. Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel–Lindau disease and HIF-2alpha gain-of-function mutation. FASEB J 25:20012011.
  • Furlow PW, Percy MJ, Sutherland S, Bierl C, McMullin MF, Master SR, Lappin TRJ, Lee FS. 2009. Erythrocytosis-associated HIF-2alpha mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline. J Biol Chem 284:90509058.
  • Furukawa T, Narita M, Sakaue M, Otsuka T, Kuroha T, Masuko M, Azegami T, Kishi K, Takahashi M, Utsumi J, Koike T, Aizawa Y. 1997. Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor. Br J Haematol 99:222227.
  • Gale DP, Harten SK, Reid CD, Tuddenham EG, Maxwell PH. 2008. Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with HIF2α mutation. Blood 112:919921.
  • Gordeuk VR, Sergueeva AI, Miasnikova GY, Okhotin D, Voloshin Y, Choyke PL, Butman JA, Jedlickova K, Prchal JT, Polyakova LA. 2004. Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythaemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood 103:39243929.
  • Gordeuk VR, Prchal JT. 2006. Vascular complications in Chuvash polycythaemia. Semin Thromb Hemost 32:289294.
  • Haase VH. 2010. Hypoxic regulation of erythropoiesis and iron metabolism. Am J Physiol Renal Physiol 299:F1F13.
  • Hickey MM, Lam JC, Bezman NA, Rathmell WK, Simon MC. 2007. von Hippel–Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis. J Clin Invest 117:38793889.
  • Hoyer JD, Allen SL, Beutler E, Kubik K, West C, Fairbanks VF. 2004. Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Am J Hematol 75:205208.
  • Huang LJ, Shen YM, Bulut GB. 2010. Advances in understanding the pathogenesis of primary familial and congenital polycythaemia. Br J Haematol 148:844852.
  • Iliopoulos O, Ohh M, Kaelin WG. 1998. pVHL19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation. Proc Natl Acad Sci USA 95:1166111666.
  • Kato H, Inoue T, Asanoma K, Nishimura C, Matsuda T, Wake N. 2006. Induction of human endometrial cancer cell senescence through modulation of HIF-1α activity by EGLN1. Int J Cancer 118:11441153.
  • Koller O, Sandvei R, Sagen N.1980. High Hemoglobin levels during pregnancy and fetal risk. Int J Gynaecol Obstet 18:5356.
  • Kralovics R, Indrak K, Stopka T, Berman BW, Prchal JF, Prchal JT. 1997a. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias. Blood 90:20572061.
  • Kralovics R, Sokol L, Broxson EH, Jr., Prchal JT. 1997b. The erythropoietin receptor gene is not linked with the polycythemia phenotype in a family with autosomal dominant primary polycythemia. Proc Assoc Am Physicians 109:580585.
  • Kralovics R, Sokol L, Prchal JT. 1998. Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia. Clin Invest 102:124129.
  • Kralovics R, Prchal JT. 2001. Genetic heterogeneity of primary familial and congenital polycythemia. Am J Hematol 68:115121.
  • Kunz M, Ibrahim SM. 2003. Molecular responses to hypoxia in tumor cells. Molecular cancer 2:23.
  • Ladroue C, Carcenac R, Leporrier M, Gad S, Le Hello C, Galateau-Salle F, Feunteun J, Pouysségur J, Richard S, Gardie B. 2008. PHD2 mutation and congenital erythrocytosis with paraganglioma. N Engl J Med 359: 26852692.
  • Ladroue C, Hoogewijs D, Gad S, Carcenac R, Storti F, Barrois M, Gimenez-Roqueplo AP, Leporrier M, Casadevall N, Hermine O, Kiladjian JJ, Baruchel A, et al. 2012. Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia. Haematologica 97:914.
  • Lanikova L, Lorenzo F, Yang C, Vankayalapati H, Drachtman R, Divoky V, Prchal JT. 2013. Novel homozygous VHL mutation in exon 2 is associated with congenital polycythemia but not with cancer. Blood 121:39183924.
  • Le Couedic JP, Mitjavila MT, Villeval JL, Feger F, Gobert S, Mayeux P, Casadevall N, Vainchenker W. 1996. Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies. Blood 87:15021511.
  • de la Chapelle A, Träskelin AL, Juvonen E. 1993. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci USA 90:44954499.
  • Lee FS. 2008. Genetic causes of erythrocytosis and the oxygen-sensing pathway. Blood Rev 22:321332.
  • Lee FS, Percy MJ. 2011. The HIF pathway and erythrocytosis. Annu Rev Pathol 6:165192.
  • Lemarchandel V, Joulin V, Valentin C, Rosa R, Galactéros F, Rosa J, Cohen-Solal M. 1992. Compound heterozygosity in a complete erythrocyte bisphosphoglycerate mutase deficiency. Blood 80:26432649.
  • Lorenzo FR, Simonson TS, Yang Y, Ge R, Prchal JT. 2010. A novel PHD2 mutation associated with Tibetan genetic adaptation to high altitude hypoxia. ASH Annual Meeting Abstracts. Paper34402.
  • Lorenzo FR, Yang C, Ng Tang Fui M, Vankayalapati H, Zhuang Z, Huynh TG, Pacak KPJ. 2012. A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma. J Mol Med (Berl) 91:507512.
  • Lorenzo FR, Yang C, Lanikova L, Butros L, Zhuang Z, Prchal JT. 2013. Novel compound VHL heterozygosity (VHL T124A/L188V) associated with congenital polycythaemia. Br J Haematol. 162:851853.
  • Lok CN, Ponka P. 1999. Identification of a hypoxia response element in the transferrin receptor gene. J Biol Chem 274:2414724152.
  • Liu E, Percy MJ, Amos CI, Guan Y, Shete S, Stockton DW, McMullin MF, Polyakova LA, Ang SO, Pastore YD, Jedlickova K, Lappin TR, et al. 2004. The worldwide distribution of the VHL 598C>T mutation indicates a single founding event. Blood 103:19371940.
  • Martini M, Teofili L, Cenci T, Giona F, Torti L, Rea M, Foà R, Leone G, Larocca LM. 2008. A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis. Haematologica 93:10681071.
  • McMullin MF, Bareford D, Campbell P, Green AR, Harrison C, Hunt B, Oscier D, Polkey MI, Reilly JT, Rosenthal E, Ryan K, Pearson TC, et al. 2005. Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis. Br J Haematol 130:174195.
  • McMullin MF. 2008. The classification and diagnosis of erythrocytosis. Int J Lab Hematol 30:447459.
  • Mole DR, Ratcliffe PJ. 2008. Cellular oxygen sensing in health and disease. Pediatr Nephrol 23:681694.
  • Nakamura Y, Komatsu N, Nakauchi H. 1992. A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science 257:11381141.
  • Nordstrom-O'Brien M, van der Luijt RB, van Rooijen E, van den Ouweland AM, Majoor-Krakauer DF, Lolkema MP, van Brussel A, Voest EE, Giles RH. 2010. Genetic analysis of von Hippel–Lindau disease. Hum Mutat 31:521537.
  • O'Rourke K, Fairbairn DJ, Jackson KA, Morris KL, Tey SK, Kennedy GA. 2011. A novel mutation of the erythropoietin receptor gene associated with primary familial and congenital polycythaemia. Int J Hematol 93:542544.
  • Pastore YD, Jelinek J, Ang S, Guan Y, Liu E, Jedlickova K, Krishnamurti L, Prchal JT. 2003a. Mutations in the VHL gene in sporadic apparently congenital polycythemia. Blood 101:15911595.
  • Pastore YD, Jedlickova K, Guan Y, Liu E, Fahner J, Hasle H, Prchal JF, Prchal JT. 2003b. Mutations of von Hippel–Lindau tumor-suppressor gene and congenital polycythemia. Am J Hum Genet 73:412419.
  • Patnaik MM, Tefferi A. 2009. The complete evaluation of erythrocytosis: congenital and acquired. Leukemia 23:834844.
  • Percy MJ, McMullin MF, Jowitt SN, Potter M, Treacy M, Watson WH, Lappin TR. 2003. Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry. Blood 102:10971099.
  • Percy MJ, Zhao Q, Flores A, Harrison C, Lappin TRJ, Maxwell PH, McMullin MF, Lee FS. 2006. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc Natl Acad Sci USA 103:654659.
  • Percy MJ, Furlow PW, Jones FGC, Lappin TRJ, Lee FS, McMullin MF. 2007. Erythrocytosis caused by mutations in the PHD2 and VHL genes. ASH Annual Meeting Abstracts 110:3663.
  • Percy MJ, Furlow PW, Lucas GS, Li X, Lappin TR, McMullin MF, Lee FS. 2008a. A gain-of-function mutation in the HIF2A gene in familial erythrocytosis. N Engl J Med 358:162168.
  • Percy MJ, Beer PA, Campbell G, Dekker AW, Green AR, Oscier D, Rainey MG, van Wijk R, Wood M, Lappin TR, McMullin MF, Lee FS. 2008b. Novel exon 12 mutations in the HIF2a gene associated with erythrocytosis. Blood 111:54005402.
  • Percy MJ, Butt NN, Crotty GM, Drummond MW, Harrison C, Jones GL, Turner M, Wallis J, McMullin MF. 2009. Identification of high oxygen affinity hemoglobin variants in the investigation of patients with erythrocytosis. Haematologica 94:13211322.
  • Percy MJ, Chung YJ, Harrison C, Mercieca J, Hoffbrand AV, Dinardo CL, Santos PC, Fonseca GH, Gualandro SF, Pereira AC, Lappin TR, McMullin MF, Lee FS. 2012. Two new mutations in the HIF2A gene associated with erythrocytosis. Am J Hematol 87:439442.
  • Perrotta S, Nobili B, Ferraro M, Migliaccio C, Borriello A, Cucciolla V, Martinelli V, Rossi F, Punzo F, Cirillo P, Parisi G, Zappia V, et al. 2006. Von Hippel–Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster. Blood 107:514519.
  • Perrotta S, Cucciolla V, Ferraro M, Ronzoni L, Tramontano A, Rossi F, Scudieri AC, Borriello A, Roberti D, Nobili B, Cappellini MD, Oliva A, et al. 2010. EPO receptor gain-of-function causes hereditary polycythemia, alters CD34+ cell differentiation and increases circulating endothelial precursors. PLoS One 5:e12015.
  • Perrotta S, Stiehl DP, Punzo F, Scianguetta S, Borriello A, Bencivenga D, Casale M, Nobili B, Fasoli S, Balduzzi A, Cro L, Nytko KL, et al. 2013. Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in normal range. Haematologica. 98:16241632.
  • Petersen KB, Hokland P, Petersen GB, Nyvold CG, Brorson PK, Bruun PG, Guldborg NC. 2004. Erythropoietin receptor defect: a cause of primary polycythaemia. Br J Haematol 125:537538.
  • Prchal JT, Semenza GL, Prchal J, Sokol L. 1995. Familial polycythemia. Science 268:18311832.
  • Prchal JT, Sokol L. 1996. “Benign erythrocytosis” and other familial and congenital polycythemias. Eur J Haematol 57:263268.
  • Randi ML, Murgia A, Putti MC, Martella M, Casarin A, Opocher G, Fabris F. 2005. Low frequency of VHL gene mutations in young individuals with polycythemia and high serum erythropoietin. Haematologica 90:689691.
  • Rathmell WK, Hickey MM, Bezman NA, Chmielecki CA, Carraway NC, Simon MC. 2004. In vitro and in vivo models analyzing von Hippel–Lindau disease-specific mutations. Cancer Res 64:85958603.
  • Rosa R, Prehu MO, Beuzard Y, Rosa J. 1978. The first case of a complete deficiency of diphosphoglycerate mutase in human erythrocytes. J Clin Invest 62:907915.
  • Rives S, Pahl HL, Florensa L, Bellosillo B, Neusuess A, Estella J, Debatin KM, Kohne E, Schwarz K, Cario H. 2007. Molecular genetic analyses in familial and sporadic congenital primary erythrocytosis. Haematologica 92:674677.
  • Russell RC, Sufan RI, Zhou B, Heir P, Bunda S, Sybingco SS, Greer SN, Roche O, Heathcote SA, Chow VW, Boba LM, Richmond TD, et al. 2011. Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia. Nat Med 17:845853.
  • Scortegagna M, Morris MA, Oktay Y, Bennett M, Garcia JA. 2003. The HIF family member EPAS1/HIF-2alpha is required for normal hematopoiesis in mice. Blood 102:16341640.
  • Smith TG, Brooks JT, Balanos GM, Lappin TR, Layton DM, Leedham DL, Liu C, Maxwell PH, McMullin MF, McNamara CJ, Percy MJ, Pugh CW, et al. 2006. Mutation of von Hippel–Lindau tumour suppressor and human cardiopulmonary physiology. PLoS Med 3:11781186.
  • Sokol L, Prchal JF, D'Andrea A, Rado TA, Prchal JT. 1994. Mutation in the negative regulatory element of the erythropoietin receptor gene in a case of sporadic primary polycythemia. Exp Hematol 22:447453.
  • Sokol L, Luhovy M, Guan Y, Prchal JF, Semenza GL, Prchal JT. 1995. Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin. Blood 86:1522.
  • Thom CS, Dickson CF, Gell DA, Weiss MJ. 2013. Hemoglobin variants: biochemical properties and clinical correlates. Cold Spring Harb Perspect Med 3:a011858.
  • Toledo RA, Qin Y, Srikantan S, Morales NP, Li Q, Deng Y, Kim S, Pereira MA, Toledo SP, Su X, Aguiar RC, Dahia P. 2013. In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas. Endocr Relat Cancer. 20:349359.
  • Van Maerken T, Hunninck K, Callewaert L, Benoit Y, Laureys G, Verlooy J. 2004. Familial and congenital polycythemias: a diagnostic approach. J Pediatr Hematol Oncol 26:407416.
  • Van Wijk R, Sutherland S, Van Wesel ACW, Huizinga EG, Percy MJ, Bierings M, Lee FS. 2010. Erythrocytosis associated with a novel missense mutation in the HIF2A gene. Haematologica 95:829832.
  • Weatherall DJ, Clegg JB, Callender ST, Wells RM, Gale RE, Huehns ER, Perutz MF, Viggiano G, Ho C. 1977. Haemoglobin Radcliffe (alpha2beta299(Gi)Ala): a high oxygen-affinity variant causing familial polycythaemia. Br J Haematol 35:177191.
  • Wang GL, Jiang BH, Rue EA, Semenza GL. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:55105514.
  • Warnecke C, Zaborowska Z, Kurreck J, Erdmann VA, Frei U, Wiesener M, Eckardt KU. 2004. Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J 18:14621464.
  • Watowich SS, Xie X, Klingmuller U, Kere J, Lindlof M, Berglund S, de la Chapelle A. 1999. Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state. Blood 94:25302532.
  • Wenger RH, Stiehl DP, Camenisch G. 2005. Integration of oxygen signaling at the consensus HRE. Sci STKE 306:re12.
  • Woodward ER, Wall K, Forsyth J, Macdonald F, Maher ER. 2007. VHL mutation analysis in patients with isolated central nervous system haemangioblastoma. Brain 130:836842.
  • Yang C, Sun MG, Matro J, Huynh TT, Rahimpour S, Prchal JT, Lechan R, Lonser R, Pacak K, Zhuang Z. 2013. Novel HIF2A mutations disrupt oxygen sensing leading to polycythemia, paragangliomas and somatostatinomas. Blood. 121:25632566.
  • Zhang FL, Shen GM, Liu XL, Wang F, Zhao HL, Yu J, Zhang JW. 2011. Hypoxic induction of human erythroid-specific δ-aminolevulinate synthase mediated by hypoxia-inducible factor 1. Biochemistry 50:11941202.
  • Zhang FL, Shen GM, Liu XL, Wang F, Zhao YZ, Zhang JW. 2012. Hypoxia-inducible factor 1-mediated human GATA1 induction promotes erythroid differentiation under hypoxic conditions. J Cell Mol Med 16:18891899.
  • Zhuang Z, Yang C, Lorenzo F, Merino M, Fojo T, Kebebew E, Popovic V, Stratakis CA, Prchal JT, Pacak K. 2012. Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N Engl J Med 367:922930.